Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

2011 FDA drug approvals

Nature Reviews Drug Discovery volume 11, pages 91–94 (2012)Cite this article

Subjects

The US FDA approved 30 new therapeutics last year, including 11 first-in-class agents.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: FDA drug approvals since 1993.
Authors
  1. Asher Mullard
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. 2011 FDA drug approvals. Nat Rev Drug Discov 11, 91–94 (2012). https://doi.org/10.1038/nrd3657

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3657

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research